Ryan J Shaw1,2, Q Yang1, A Barnes1, D Hatch1, M J Crowley3,4, A Vorderstrasse5, J Vaughn1, A Diane1, A A Lewinski3, M Jiang6, J Stevenson1, D Steinberg1. 1. School of Nursing, Duke University, Durham, North Carolina, USA. 2. Center for Applied Genomics & Precision Medicine, School of Medicine, Duke University, Durham, North Carolina, USA. 3. Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA. 4. Division of Endocrinology, Diabetes and Metabolism, Duke University School of Medicine, Durham, North Carolina, USA. 5. College of Nursing, New York University, New York, New York, USA. 6. Department of Biostatistics & Bioinformatics, School of Medicine, Duke University, Durham, North Carolina, USA.
Abstract
OBJECTIVE: The purpose of this study was to examine the use of multiple mobile health technologies to generate and transmit data from diverse patients with type 2 diabetes mellitus (T2DM) in between clinic visits. We examined the data to identify patterns that describe characteristics of patients for clinical insights. METHODS: We enrolled 60 adults with T2DM from a US healthcare system to participate in a 6-month longitudinal feasibility trial. Patient weight, physical activity, and blood glucose were self-monitored via devices provided at baseline. Patients also responded to biweekly medication adherence text message surveys. Data were aggregated in near real-time. Measures of feasibility assessing total engagement in device submissions and survey completion over the 6 months of observation were calculated. RESULTS: It was feasible for participants from different socioeconomic, educational, and racial backgrounds to use and track relevant diabetes-related data from multiple mobile health devices for at least 6 months. Both the transmission and engagement of the data revealed notable patterns and varied by patient characteristics. DISCUSSION: Using multiple mobile health tools allowed us to derive clinical insights from diverse patients with diabetes. The ubiquitous adoption of smartphones across racial, educational, and socioeconomic populations and the integration of data from mobile health devices into electronic health records present an opportunity to develop new models of care delivery for patients with T2DM that may promote equity as well.
OBJECTIVE: The purpose of this study was to examine the use of multiple mobile health technologies to generate and transmit data from diverse patients with type 2 diabetes mellitus (T2DM) in between clinic visits. We examined the data to identify patterns that describe characteristics of patients for clinical insights. METHODS: We enrolled 60 adults with T2DM from a US healthcare system to participate in a 6-month longitudinal feasibility trial. Patient weight, physical activity, and blood glucose were self-monitored via devices provided at baseline. Patients also responded to biweekly medication adherence text message surveys. Data were aggregated in near real-time. Measures of feasibility assessing total engagement in device submissions and survey completion over the 6 months of observation were calculated. RESULTS: It was feasible for participants from different socioeconomic, educational, and racial backgrounds to use and track relevant diabetes-related data from multiple mobile health devices for at least 6 months. Both the transmission and engagement of the data revealed notable patterns and varied by patient characteristics. DISCUSSION: Using multiple mobile health tools allowed us to derive clinical insights from diverse patients with diabetes. The ubiquitous adoption of smartphones across racial, educational, and socioeconomic populations and the integration of data from mobile health devices into electronic health records present an opportunity to develop new models of care delivery for patients with T2DM that may promote equity as well.
Authors: Lena Mamykina; Matthew E Levine; Patricia G Davidson; Arlene M Smaldone; Noemie Elhadad; David J Albers Journal: J Am Med Inform Assoc Date: 2016-03-16 Impact factor: 4.497
Authors: Massimiliano de Zambotti; Aimee Goldstone; Stephanie Claudatos; Ian M Colrain; Fiona C Baker Journal: Chronobiol Int Date: 2017-12-13 Impact factor: 2.877
Authors: Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda Journal: J Biomed Inform Date: 2019-05-09 Impact factor: 6.317
Authors: Santosh Kumar; Wendy J Nilsen; Amy Abernethy; Audie Atienza; Kevin Patrick; Misha Pavel; William T Riley; Albert Shar; Bonnie Spring; Donna Spruijt-Metz; Donald Hedeker; Vasant Honavar; Richard Kravitz; R Craig Lefebvre; David C Mohr; Susan A Murphy; Charlene Quinn; Vladimir Shusterman; Dallas Swendeman Journal: Am J Prev Med Date: 2013-08 Impact factor: 5.043
Authors: Corrine I Voils; Matthew L Maciejewski; Rick H Hoyle; Bryce B Reeve; Patrick Gallagher; Christopher L Bryson; William S Yancy Journal: Med Care Date: 2012-12 Impact factor: 2.983
Authors: Jacqueline Vaughn; Donruedee Kamkhoad; Ryan J Shaw; Sharron L Docherty; Arvind P Subramaniam; Nirmish Shah Journal: J Am Med Inform Assoc Date: 2021-07-14 Impact factor: 4.497